Berookhim Boback M, Palermo Gianpiero D, Zaninovic Nikica, Rosenwaks Zev, Schlegel Peter N
Department of Urology, Weill Cornell Medical College, New York, New York; Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York.
Ronald O. Perelman and Claudia Cohen Center for Reproductive Medicine, Weill Cornell Medical College, New York, New York.
Fertil Steril. 2014 Nov;102(5):1282-6. doi: 10.1016/j.fertnstert.2014.08.007. Epub 2014 Oct 30.
To study the outcomes of microdissection testicular sperm extraction (microTESE) among men with pure Sertoli cell-only histology on diagnostic testicular biopsy.
Retrospective cohort study.
Tertiary referral center.
PATIENT(S): Six hundred forty patients with pure Sertoli cell-only histology on testicular biopsy who underwent microTESE by a single surgeon.
INTERVENTION(S): MicroTESE.
MAIN OUTCOME MEASURE(S): Sperm retrieval rates.
RESULT(S): Overall, 44.5% of patients with Sertoli cell only had sperm retrieved with microTESE. No difference was noted in sperm retrieval rates based on testis volume (≥15 mL vs. <15 mL, 35.3% vs. 46.1%, respectively). Patients with ≥15 mL testicular volume and FSH 10-15 mU/mL had the worst prognosis, with a sperm retrieval rate of 6.7%.
CONCLUSION(S): Patients with previous testicular biopsy demonstrating Sertoli cell-only histology can be counseled that they have a reasonable likelihood of sperm retrieval with the contemporary delivery of microTESE. Given this finding, the utility of testicular biopsy before microTESE is further questioned.
研究诊断性睾丸活检显示为单纯支持细胞组织学的男性患者行显微取精术(microTESE)的结果。
回顾性队列研究。
三级转诊中心。
640例睾丸活检显示为单纯支持细胞组织学的患者,均由同一位外科医生进行显微取精术。
显微取精术。
精子获取率。
总体而言,单纯支持细胞患者中有44.5%通过显微取精术获取到了精子。基于睾丸体积(≥15 mL与<15 mL,精子获取率分别为35.3%和46.1%),精子获取率无差异。睾丸体积≥15 mL且促卵泡生成素(FSH)为10 - 15 mU/mL的患者预后最差,精子获取率为6.7%。
对于既往睾丸活检显示为单纯支持细胞组织学的患者,可以告知他们采用当代显微取精术有合理的精子获取可能性。鉴于这一发现,显微取精术前进行睾丸活检的实用性受到进一步质疑。